US · guidance
BOP Program Statement 5514.01 § 5
DRUG TESTING PROCEDURES
§ 550.31 Procedures.
(a) Staff of the same sex as the inmate tested shall directly supervise the giving of the urine
sample. If an inmate is unwilling to provide a urine sample within two hours of a request for it,
staff ordinarily shall file an incident report. No waiting period or extra time need be allowed
for an inmate who directly and specifically refuses to provide a urine sample. To eliminate the
possibility of diluted or adulterated samples, staff shall keep the inmate under direct visual
supervision during this two-hour period, or until a complete sample is furnished. To assist the
inmate in giving the sample, staff shall offer the inmate eight ounces of water at the beginning
of the two-hour time period. An inmate is presumed to be unwilling if the inmate fails to
provide a urine sample within the allotted time period. An inmate may rebut this presumption
during the disciplinary process.
(b) Institution staff shall determine whether a justifiable reason exists, (e.g., use of prescribed
medication) for any positive urine test result. If the inmate's urine test shows a positive test
result for the presence of drugs which cannot be justified, staff shall file an incident report.
An inmate testing positive for prohibited drugs is subject to disciplinary action under 28 CFR
part 541 and the Program Statement Inmate Discipline Program. All test results for drug testing
will be entered into the approved Bureau intelligence computer database.
5514.01 5/7/2026 Federal Regulations from 28 CFR: this type. Implementing instructions: this type. 5
Ordinarily, an inmate is expected to provide a urine sample within two hours of the request, but
the Captain (or Lieutenant) may extend the time if warranted (e.g., the inmate has a documented
medical or psychological issue or is participating in an approved religious fast).
Upon request to provide a urine sample for drug testing, the inmate will be offered eight ounces
of fluids and thereafter, every 30 minutes until the inmate provides a sufficient amount of a urine
sample. If the testing time is approved for an extension, the total fluids ingested must not exceed
40 ounces. All drug tests must be conducted under direct staff supervision.
a. Refusal to Test. An inmate refusing a drug test is subject to disciplinary action. Staff must
document the circumstances of the inmate’s refusal to test. Refusal to test can be demonstrated
verbally or by actions. An inmate can demonstrate refusal to test by:
■ stating they will not take the test,
■ failing to appear for a drug or alcohol test,
■ failing to remain at the collections site until the collection process is complete,
■ being presumed to be unwilling if they fail to provide a urine sample within the allotted time,
■ failing to permit the observation or monitoring of a provision of specimen,
■ failing to provide a sufficient amount of a specimen when directed,
■ failing to cooperate with any part of the testing process,
■ failing to follow the observer’s instructions,
■ bringing materials to the collection site for the purpose of adulterating, substituting, or
diluting the specimen,
■ attempting to adulterate, substitute, or dilute the specimen,
■ possessing or wearing a prosthetic or other device that could be used to interfere with the
collection process, and/or
■ admitting they adulterated or substituted the specimen.
Drug test sample amounts will be determined by manufacturers. A urine sample is considered to
be the specimen cup filled to the mark indicated. Staff should refer to the urine collection
procedures provided by the contracted laboratory. Retesting at the inmate’s request is not
permitted.
Drug tests which require confirmation must be sent to the laboratory established by national
contract. The types of drugs screened and tested for, confirmation levels, and laboratory
reporting will be established by the national contract.
An incident report for positive drug tests is forwarded in accordance with the Program Statement
Inmate Discipline Program and uploaded, along with the laboratory conformation of the
positive tests, into the Bureau’s approved intelligence computer database. Incident reports
require laboratory confirmation and documentation from a Bureau pharmacist that the positive
5514.01 5/7/2026 Federal Regulations from 28 CFR: this type. Implementing instructions: this type. 6
test is not a result of legally prescribed medication before they are written. There is no
requirement to maintain laboratory forms for negative tests.
History
PS 5514.01 dated 2026-05-07
Provenance
- Source
- bop.gov
- Retrieved
- 2026-09-20
- Edition
- bop-ps-2026-09-20
- Content hash
3eb0cd7f232588ae8e8b1d783ab6b79de4629126f7dfde9dfeacc4ac920bed45
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.